Agios Pharmaceuticals, Inc. AGIO
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Greg Harrison | Scotiabank | 30.1 $ | 71 $ | 40.90 % | 02/05/2025 |
| Danielle Brill | Raymond James | 44.43 $ | 51 $ | 6.57 % | 31/10/2024 |
| Andrew Berens | Leerink Partners | 45.61 $ | 56 $ | 10.39 % | 27/09/2024 |
| Chris Raymond | Raymond James | 44.05 $ | 56 $ | 11.95 % | 10/09/2024 |
| Chris Raymond | Raymond James | 43.42 $ | 55 $ | 11.58 % | 17/06/2024 |
| Gregory Renza | RBC Capital | 44.26 $ | 53 $ | 8.74 % | 03/06/2024 |
| Chris Raymond | Raymond James | 38.39 $ | 45 $ | 6.61 % | 28/05/2024 |
| Peter Lawson | Barclays | 55.8 $ | 70 $ | 14.20 % | 30/04/2021 |